GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DongKook Pharmaceutical Co Ltd (XKRX:086450) » Definitions » Total Inventories

DongKook Pharmaceutical Co (XKRX:086450) Total Inventories : ₩138,343 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is DongKook Pharmaceutical Co Total Inventories?

DongKook Pharmaceutical Co's total inventories for the quarter that ended in Dec. 2023 was ₩138,343 Mil. DongKook Pharmaceutical Co's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was ₩137,972 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. DongKook Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was ₩-251.69.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. DongKook Pharmaceutical Co's Days Inventory for the three months ended in Dec. 2023 was 151.82.

Inventory Turnover measures how fast the company turns over its inventory within a year. DongKook Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.60.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. DongKook Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.73.


DongKook Pharmaceutical Co Total Inventories Historical Data

The historical data trend for DongKook Pharmaceutical Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DongKook Pharmaceutical Co Total Inventories Chart

DongKook Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60,867.11 79,048.46 102,590.93 120,151.52 138,343.35

DongKook Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120,151.52 119,618.48 128,797.18 137,601.05 138,343.35

DongKook Pharmaceutical Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


DongKook Pharmaceutical Co  (XKRX:086450) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

DongKook Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

Net-Net Working Capital Per Share (Q: Dec. 2023 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(94159.871+0.75 * 161106.573+0.5 * 138343.347-263361.424
-385.21-31479.655)/43.9623
=-251.69

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

DongKook Pharmaceutical Co's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2023 )/Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=137972.1975/82924.506*365 / 4
=151.82

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

DongKook Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2023 ) / Average Total Inventories (Q: Dec. 2023 )
=82924.506 / 137972.1975
=0.60

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

DongKook Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=137972.1975 / 187876.226
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


DongKook Pharmaceutical Co Total Inventories Related Terms

Thank you for viewing the detailed overview of DongKook Pharmaceutical Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


DongKook Pharmaceutical Co (XKRX:086450) Business Description

Traded in Other Exchanges
N/A
Address
Dongkook Building 997-8 Daechi 3-dong, Kangnam-gu, Seoul, KOR, 135-502
DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.

DongKook Pharmaceutical Co (XKRX:086450) Headlines

No Headlines